Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.
about
Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin modelsCytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaquesHuman CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoidsCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)A chemical genetic screen in zebrafish for pathways interacting with cdx4 in primitive hematopoiesisA transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cellsCyp26b1 regulates retinoic acid-dependent signals in T cells and its expression is inhibited by transforming growth factor-β.Characterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm.Distinct populations of hepatic stellate cells in the mouse liver have different capacities for retinoid and lipid storage.Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1.Frontiers in sebaceous gland biology and pathology.Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.Retinoic acid drives aryl hydrocarbon receptor expression and is instrumental to dioxin-induced toxicity during palate development.Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.Cytochrome P450 2S1 depletion enhances cell proliferation and migration in bronchial epithelial cells, in part, through modulation of prostaglandin E(2) synthesis.Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancerPhysiological significance and expression of P450s in the developing eye.Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse modelRole of the aryl hydrocarbon receptor in drug metabolism.Species difference in the regulation of cytochrome P450 2S1: lack of induction in rats by the aryl hydrocarbon receptor agonist PCB126Phase I and Phase II enzyme polymorphisms and childhood cancer.Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.Enzymology of retinoic acid biosynthesis and degradation.Characterization of orphan human cytochromes P450.Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders.Drug-metabolizing enzymes in the skin of man, rat, and pig.Cytochromes p450 and skin cancer: role of local endocrine pathways.Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol.Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli.Approaches to deorphanization of human and microbial cytochrome P450 enzymes.Induction of cytochrome P450 enzymes: a view on human in vivo findings.Pharmacogenetics of topical and systemic treatment of psoriasis.Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions.Extrahepatic metabolism at the body's internal-external interfaces.Heterologous expression of human cytochrome P450 2S1 in Escherichia coli and investigation of its role in metabolism of benzo[a]pyrene and ellipticine.A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia.Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity.Retinoic Acid Synthesis and Degradation.Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.
P2860
Q26825940-039A54C7-1E74-4DCE-8CA9-45017149A47FQ28281019-0E8F03A1-7CF2-4015-A594-0332436426A9Q28298062-9C27F980-5D75-43ED-8B6D-DF7484A0932CQ28307304-77CC065B-A7AD-484E-8E42-16118E7012BEQ28468690-573E82E1-A60F-4DC9-A400-7DFD459643DFQ31144501-47871C32-7A19-4F42-BC28-AB7EF437A8A3Q33797982-B11B5C04-0F07-4395-822E-068FC1026124Q33953907-7F51403E-DA78-4A9B-B9BE-0CD46E387B1CQ34031775-5F8600A2-0A66-4F28-A46E-E02A2E519AE2Q34127983-2DC45302-5057-4B15-A997-6686DBF0C03DQ34778170-F08E0EA5-48B2-4450-90E4-5768E9BD5D42Q35005664-CB32F476-30B9-4802-A1F9-CE15DF4D7C77Q35122778-F3012BF7-0A01-40D8-A7CF-9C0F14B1063AQ35579852-3F767418-8FF6-49DB-9067-8A40E2F0BC79Q35956157-0066B16D-7C3D-413C-85A2-034649047C4DQ36335457-8E517544-4E81-4A43-8412-64EDCED2E923Q36387788-6431E274-02CB-4876-AAF3-F7A04EDE48E1Q36473511-F4F540B5-2E10-4E3A-B59D-9AC0407B04C1Q36497642-37D06501-4DFB-4E75-8549-A32F7EA289B3Q36572621-5606CF15-D65D-4C09-9804-038453BB4C78Q36588312-37697706-9B37-4BF8-A450-400462A3CB7FQ36668333-4779ED38-A8EC-423C-9419-766DAD57B183Q36905575-3B747900-4F95-40D8-B033-20F38D7286C3Q36920543-E408A076-5FD9-4A0B-BF60-E06032AF55DFQ36929625-17DA0BBB-759E-499C-97A1-2678A25B75E6Q36973819-A91AB0F4-2F11-4D20-8638-C41ED76138F3Q37023993-DABC33C4-2D8C-4D70-AA33-A14DB6FF4CE8Q37088368-EA0E39BF-B9BD-4F5C-AF7D-EE7946C1FF56Q37415810-8AEFCA40-CB1D-4BBD-BB97-FF05BD71427DQ37415818-AFDB87CA-5874-4155-87E8-C44D41BEFE86Q37759731-CB782C75-1D82-423A-A83F-C35F91C2A46FQ38057372-AAB3EE70-C980-4C5C-947E-84E427239FEAQ38148599-D5B6117E-5B76-4430-9CA8-D687F13B27FCQ38155921-A94F8783-8E54-4CD8-854D-22E3B8F88A0EQ38199198-7FF50318-70D1-4A3C-894F-95C5ED16DC86Q40062685-46900A2A-B619-4162-A973-0F78F1C72EEAQ40174716-62292765-729F-4949-BEC4-FC160E3588B2Q40442981-DC5E91C7-DED5-49ED-A803-86B8B61004EFQ41346430-B3BC05DB-AC25-4A4A-9646-FABA2E7F693BQ42112553-DFEAC796-EE41-4A61-8DB7-F5969AAC4DAC
P2860
Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@ast
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@en
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@nl
type
label
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@ast
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@en
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@nl
prefLabel
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@ast
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@en
Cutaneous expression of cytoch ...... iasis and other skin diseases.
@nl
P2093
P50
P1433
P1476
Cutaneous expression of cytoch ...... riasis and other skin diseases
@en
P2093
Alan T Evans
James Ferguson
Muriel M Comrie
P304
P356
10.1016/S0140-6736(03)13081-4
P407
P577
2003-04-01T00:00:00Z